星雲股份(300648.SZ):連續8個月內與寧德時代方面簽訂採購訂單累計達2.89億元
格隆匯4月6日丨星雲股份(300648.SZ)公佈,原框架合同到期後,公司於2022年1月1日與寧德時代續簽了《框架採購合同》,合同有效期:2022年1月1日至2024年12月31日。上述合同未約定合同金額,具體價格以採購訂單為準,採購訂單由雙方另行共同製作並蓋章確認。
自2021年8月7日至2022年3月31日,公司連續8個月內與寧德時代及其控股子公司簽訂採購訂單金額累計達到289,023,613.25元,佔公司2020年度經審計主營業務收入的50.47%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.